Skip to Main Content

Paper Details

Reply to Comment on: "Quality of Life in Primary Open-Angle Glaucoma and Cataract: An Analysis of VFQ-25 and OSDI from the iStent inject® Pivotal Trial".
Am J Ophthalmol
2
2022
  • 1 - 1

Datasets